Biomarker Discovery for Precision Medicine: an Artificial Intelligence based approach.

Rahoitetun hankkeen kuvaus

Biomarker development is essential in modern health care, especially in individualization of treatments and precision medicine. Omics has attracted much attention to support discovery of novel biomarkers. However, of the estimated 1M biomarkers identified in omics studies only a small fraction (<1%) has achieved FDA approval. Failures in marker development equate to lost resources, time, and credibility for the field. I aim to use Artificial Intelligence methods to efficiently mine big biomedical data and quickly assess combinations of biomarkers from large-scale omics and clinical data. These AI-driven technologies will be used to discover highly predictive biomarkers of cardiovascular disease (CVD) and Alzheimer disease (AD). By speeding up the translation of omics-driven biomarker models for clinical utility, the proposed study will bring us closer to the future of non-invasive and highly accurate medical tests, which will be accessible and affordable to everyone.
Näytä enemmän

Aloitusvuosi

2020

Päättymisvuosi

2025

Myönnetty rahoitus

Vittorio Fortino Orcid -palvelun logo
438 874 €

Muut päätökset

358037
Akatemiatutkijan tutkimuskulut(2023)
147 220 €
336275
Akatemiatutkijan tutkimuskulut(2020)
219 658 €

Rahoittaja

Suomen Akatemia

Rahoitusmuoto

Akatemiatutkijan tehtävä

Muut tiedot

Rahoituspäätöksen numero

332510

Tieteenalat

Biolääketieteet

Tutkimusalat

Systeemibiologia, bioinformatiikka

Tunnistetut aiheet

bioinformatics